HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Raises Price Target to $58

Benzinga Newsdesk www.benzinga.com Positive 71.3%

Neg 0% Neu 0% Pos 71.3%

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $38 to $58.